Your browser doesn't support javascript.
loading
MatchMiner: an open-source platform for cancer precision medicine.
Klein, Harry; Mazor, Tali; Siegel, Ethan; Trukhanov, Pavel; Ovalle, Andrea; Vecchio Fitz, Catherine Del; Zwiesler, Zachary; Kumari, Priti; Van Der Veen, Bernd; Marriott, Eric; Hansel, Jason; Yu, Joyce; Albayrak, Adem; Barry, Susan; Keller, Rachel B; MacConaill, Laura E; Lindeman, Neal; Johnson, Bruce E; Rollins, Barrett J; Do, Khanh T; Beardslee, Brian; Shapiro, Geoffrey; Hector-Barry, Suzanne; Methot, John; Sholl, Lynette; Lindsay, James; Hassett, Michael J; Cerami, Ethan.
Afiliación
  • Klein H; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA. hrklein@ds.dfci.harvard.edu.
  • Mazor T; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA. tmazor@ds.dfci.harvard.edu.
  • Siegel E; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Trukhanov P; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Ovalle A; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Vecchio Fitz CD; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Zwiesler Z; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Kumari P; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Van Der Veen B; The Hyve, Utrecht, The Netherlands.
  • Marriott E; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Hansel J; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Yu J; Department of Data Science, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA.
  • Albayrak A; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Barry S; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Keller RB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • MacConaill LE; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Lindeman N; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rollins BJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Do KT; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Beardslee B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shapiro G; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Hector-Barry S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Methot J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sholl L; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Lindsay J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hassett MJ; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cerami E; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
NPJ Precis Oncol ; 6(1): 69, 2022 Oct 06.
Article en En | MEDLINE | ID: mdl-36202909
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article